Wednesday, 14 September 2011

New website aims to clear up misconceptions about breakthrough drug Low Dose Naltrexone

WebWire - Press Release Distribution ServicesSource WebWire:

A new website has been launched by the MedInsight Research Institute to offer physicians and patients across the world the very latest information on clinical trials using Low Dose Naltrexone (LDN).   Read more here.